1.
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses
by ITOH, Yasushi
Nature (London), 2009, Vol.460 (7258), p.1021-1025
2.
Factors associated with uptake of vaccination against pandemic influenza: A systematic review
by Bish, Alison
Vaccine, 2011, Vol.29 (38), p.6472-6484
3.
Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study
by Yang, Shigui, PhD
The Lancet infectious diseases, 2017, Vol.17 (7), p.716-725
4.
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study
by Miller, Elizabeth, Prof
The Lancet (British edition), 2010, Vol.375 (9720), p.1100-1108
5.
Viral pneumonia
by Ruuskanen, Olli, Prof
The Lancet (British edition), 2011, Vol.377 (9773), p.1264-1275
6.
Psychological Predictors of Anxiety in Response to the H1N1 (Swine Flu) Pandemic
by Wheaton, Michael G
Cognitive therapy and research, 2011-02-22, Vol.36 (3), p.210-218
7.
Fast Dating Using Least-Squares Criteria and Algorithms
by To, Thu-Hien
Systematic biology, 2016-01-01, Vol.65 (1), p.82-97
8.
Safety of AS03-adjuvanted influenza vaccines: A review of the evidence
by Cohet, Catherine
Vaccine, 2019-05-21, Vol.37 (23), p.3006-3021
9.
On Reflection: The swine flu backlash
by Jeremy Laurance
The Lancet (British edition), 2010-01-30, Vol.375 (9712), p.367
10.
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes
by Melendi, Guillermina A
Nature medicine, 2011-02, Vol.17 (2), p.195-199
11.
Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis
by Echevarría-Zuno, Santiago, MD
The Lancet (British edition), 2009, Vol.374 (9707), p.2072-2079
12.
Surveillance for Guillain-Barré syndrome after 2015–2016 and 2016–2017 influenza vaccination of Medicare beneficiaries
by Arya, Deepa P
Vaccine, 2019, Vol.37 (43), p.6543-6549
13.
14.
Pacific Eclipse exercise: Value to US Indo-Pacific Command Surgeon’s Office
by Tripoli, Louis C
Vaccine, 2022-04-14, Vol.40 (17), p.2476-2477
15.
Moving the needle on racial disparity: COVID-19 vaccine trust and hesitancy
by Lin, Cheryl
Vaccine, 2022-01-03, Vol.40 (1), p.5-8
16.
Public health spending, primary care, and perceived risk promoted vaccination against H1N1
by Zhao, Anna R
Vaccine, 2022-01-21, Vol.40 (2), p.325-333
17.
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
by Black, Steven, Prof
The Lancet (British edition), 2009, Vol.374 (9707), p.2115-2122
18.
Healthcare Workers’ (HCWs) attitudes towards mandatory influenza vaccination: A systematic review and meta-analysis
by Gualano, Maria Rosaria
Vaccine, 2021-02-05, Vol.39 (6), p.901-914
19.
Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and...
by Magiri, Royford
Vaccine, 2018-03-14, Vol.36 (12), p.1606-1613
20.
Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses
by Wohlbold, Teddy John
Vaccine, 2015, Vol.33 (29), p.3314-3321
